DUOPIO
LIVE

Serial Number

97529456

Owner

Medipost America, Inc.

Attorney

Sarah E. Bro

Filing Date

Aug 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DUOPIO Trademark

Serial Number: 97529456

DUOPIO is a trademark filed by Medipost America, Inc. on August 1, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Medipost America, Inc.

8000 Tower Crescent Drive, Suite 1350
Vienna, VA 22182

Entity Type: 03

Trademark Details

Filing Date

August 1, 2022

Registration Date

Not Registered

Published for Opposition

September 26, 2023

Goods & Services

Biological preparations for use in cell cultures other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; stem cells for research or scientific purposes; clinical diagnostic preparations for scientific or research use and for clinical or medical laboratory use and cell growth media for growing cells for scientific or research use or laboratory use in cell and gene therapy

Umbilical cord tissue perivascular stem cell cryogenic preservation

Consulting services in the field of medical care; medical diagnostic and therapy services using regenerative medicine; medical therapy services using cultured cells; stem cell therapy services; cell and gene therapy services; medical diagnostic and therapy services using genetic information

Stem cell therapeutics research services; research and development of regenerative medicine, medicine and vaccines; biotechnological research; development of cell and gene therapy products; scientific research and development; product research and development; scientific research for medical purposes in the field of diseases and longevity; pharmaceutical research services; structural and functional analysis of genomes; scientific research in the field of genetics and genetic engineering; advisory services relating to biotechnology; cell culture services for scientific and research purposes, for others

Stem cells for medical or veterinary use; stem cells for medical purposes; biological preparations, namely, tissue cultures for medical or veterinary purposes

Apparatus for the regeneration of stem cells for medical purposes

Filing History

SOU TEAS EXTENSION RECEIVED
Apr 20, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2025 EXRA
SOU EXTENSION 4 GRANTED
Oct 20, 2025 EX4G
SOU EXTENSION 4 FILED
Oct 20, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 20, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2025 EXRA
SOU EXTENSION 3 GRANTED
Apr 30, 2025 EX3G
SOU EXTENSION 3 FILED
Apr 30, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2024 EXRA
SOU EXTENSION 2 GRANTED
Nov 6, 2024 EX2G
SOU EXTENSION 2 FILED
Nov 6, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 6, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 14, 2024 EX1G
SOU EXTENSION 1 FILED
May 14, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 14, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 21, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 23, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 23, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 23, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 23, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2023 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 24, 2023 GPRN
PRIORITY ACTION E-MAILED
May 24, 2023 GPRA
PRIORITY ACTION WRITTEN
May 24, 2023 CPRA
ASSIGNED TO EXAMINER
May 17, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 23, 2022 NWOS
NEW APPLICATION ENTERED
Aug 4, 2022 NWAP